AQUIOS Reagents by Beckman Coulter Life Sciences

Manufacturer Beckman Coulter Life Sciences  |  Available Worldwide
AQUIOS reagents are optimized for peak performance when used with the AQUIOS CL Flow Cytometer. High reliability with no need to mix your monoclonal antibodies.

AQUIOS Reagents by Beckman Coulter Life Sciences product image
AQUIOS Reagents
Request Pricing

Receive your quote directly from the manufacturer.

0 Scientists have reviewed this product

Write the First Review

No Reviews


The analysis of CD34+ hematopoietic stem and progenitor cells is a highly regulated test in clinical flow cytometry. 
The AQUIOS STEM System combines the automation of the AQUIOS CL with the benefits of a stem cell enumeration solution adaptable to your laboratory needs. 


  • Complete automation of the preparation and analysis
  • Flexible assay setup to run 3 different panels as part of the IVD solution
  • 2-level process control with barcoded assay sheets
  •  Prioritized handling of emergency samples
  • Full traceability of reagents ensured via barcodes
  • Processing at room temperature with an IVD compliant lysis and beads

AQUIOS STEM System is available in countries that accept the CE mark as the basis of their country specific registration.
Not available in the US. 
AQUIOS Tetra Reagents

Fast, Efficient, High Throughput Lymphocyte Subset Analysis

In the clinical management of immune deficiency diseases, accurately counting the absolute cell numbers of leukocyte subsets and measuring the percentage of individual subtypes in blood is critical. 

The AQUIOS CL flow cytometer in combination with AQUIOS Tetra reagents provides a Single Platform Technology (SPT) for lymphocyte subset analysis and enumeration without the need for counting beads.

AQUIOS Tetra system tests for simultaneous identification and enumeration of T, B, and NK lymphocytes in whole blood are proven for reliability and precision.

AQUIOS PLG (PanLeukoGating) – Affordable, Reliable CD4 Testing

By focusing on the most essential parameters for monitoring HIV therapies (CD45 vs CD4), AQUIOS PLG addresses cost, complexity, and the time previously required by labor-intensive processes to provide busy laboratories with an affordable, high-performance monitoring solution that also offers standardization and simplicity. Its efficient operation takes CD4 testing to new places.

AQUIOS PLG (PanLeukoGating) Panel is available in Angola, Botswana, Ethiopia, Ghana, Ivory Coast, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Rwanda, South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe. AQUIOS PLG Panel is not available in any other markets, including the United States and Europe.